Summary
Immunogenicity and relative attenuation were examined for the following Tian Tan strain vaccinia-rabies recombinant viruses: 1) NGc-1, which coexpresses the glycoprotein (G) and nucleocapsid protein (N) of the rabies virus Challenge Virus Standard (CVS) strain; 2) Nc-1, which expresses the CVS N; 3) Gc-2, Gc-3, Gc-4, and Gc-5, which express CVS G via promoters from different vaccinia strains or from different vaccinia genome loci; 4) Ga-1, which expresses the G of rabies virus strain aG; and 5) Gas-1; which expresses the carboxyl-truncated G ectodomain (Gs) of strain aG. All but Nc-1 and Gas-1 induced rabies virus neutralizing antibodies (VNAs) and protected groups of mice at very high frequencies from intramuscular (IM) or intracranial (IC) challenge with CVS or SW1 Shanghai dog street rabies virus (SRV); Nc-1 and Gas-1 were partly protective, more frequently against IM challenge. NGc-1 and Gc-5 appeared to induce high levels of VNAs sooner after immunization than the other constructs in mice. Relative attenuation assessed by IM infection of neonatal mice, IC infection of adult mice, and intradermal infection of rabbits with varying doses was best for NGc-1. All the recombinants were at least 100-fold more attenuated than the parent, Tian Tan vaccinia virus. Gc-2, Gc-3, Gc-4, Gc-5, and NGc-1 induced VNAs after immunization of dogs, and a subset of VNA-positive animals vaccinated with NGc-1 or Gc-3 were protected against an otherwise lethal IM injection of SRV at 21 days after vaccination.
Similar content being viewed by others
References
Artois M, Charlton KM, Tolson ND, Casey GA, Knowles MK, Campbell JB (1990) Vaccinia recombinant virus expressing the rabies virus glycoprotein: safety and efficacy trials in Canadian wildlife. Can J Vet Res 54: 504–507
Brochier B, Blancou J, Thomas I, Languet B, Artois M, Kieny MP, Lecocq JP, Costy F, Desmettre P, Chappuis G, Pastoret PP (1989) Use of recombinant vaccinia-rabies glycoprotein virus for oral vaccination of wildlife against rabies: innocuity to several non-target bait consuming species. J Wildl Dis 26: 540–547
Cadoz M, Strady A, Meignier B, Taylor J, Tartaglia J, Paoletti E, Plotkin S (1992) Immunisation with canarypox virus expressing rabies glycoprotein. Lancet 339: 1429–1432
Cai B, Hu QL, Zhu JH (1993) Alkaline phosphatase anti-alkaline phosphatase complex used in screening and purity examination of recombinant vaccinia viruses. Chin J Exp Clin Virol 7: 65–67
Cai B, Ying BL, Hu QL, Chen LM, Li CP, Nan HG, Jiang LX, Zhu JH (1993) Observation on immunoeffects in dogs of recombinant vaccinia virus expressing rabies virus glycoprotein. Chin J Zoonoses 9: 2–4
Cai B, Zhu JH, Hu QL, Esposito JJ, Hou YD (1993) Expression of rabies virus glycoprotein with vaccinia virus Tian Tan strain. Chin J Microbiol Immunol 13: 118–120
Cai B, Zhu JH, Hu QL, Zhao WG, Wang JL, Zhu YT (1994) Construction of a recombinant vaccinia virus as the rabies vaccine strain for human beings. Chin J Exp Clin Virol 8: 105–108
Chen LM, Zhu JH, Wang JL (1992) Observation on immunogenic effect of expression of the rabies virus glycoprotein by vaccinia virus recombinant (422 strain). Chin J Zoonoses 8: 2–6
Esposito JJ, Brechling K, Baer G, Moss B (1987) Vaccinia virus recombinants expressing rabies virus glycoprotein protect against rabies. Virus Genes 1: 7–21
Esposito JJ, Sumner JW, Brown DR, Ebert JW, Shaddock JH, Bai XH, Dobbins JG, Fekadu M (1992) Raccoon poxvirus rabies glycoprotein recombinant oral vaccine for wildlife: further efficacy and safety studies and serosurvey for raccoon poxvirus. In: Brown F, Chanock RM, Ginsberg H, Lerner RA (eds) Vaccines 92: Modern approaches to new vaccines including prevention of AIDS. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 321–330
Fekadu M, Shaddock JH, Sumner JW, Sanderlin DW, Knight JC, Esposito JJ, Baer GM (1991) Oral vaccination of skunks with raccoon poxvirus recombinants expressing the rabies glycoprotein or the nucleoprotein. J Wildl Dis 27: 681–684
Fekadu M, Sumner JW, Shaddock JH, Sanderlin DW, Baer GM (1992) Sickness and recovery of dogs challenged with a street rabies virus after vaccination with a vaccinia virus recombinant expressing rabies virus N protein. J Virol 66: 2601–2604
Kieny MP, Lathe R, Drillien R, Sphener D, Skory S, Schmitt D (1984) Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature 312: 163–166
Li PP, Chen LM, Zhu JH (1993) Isolation of vaccinia virus recombinants expressing rabies virus glycoprotein by using Lac-Z gene coexpression. Virol Senica 8: 293–295
Lin F, Zhu JH, Chen LM, Hou YD, Esposito JJ (1992) Construction and characteristics of vaccinia virus recombinants expressing rabies virus glycoprotein. Chin J Virol 8: 210–217
Lodmell DL, Esposito JJ, Ewalt LC (1993) Rabies virus anti-nucleoprotein antibody protects against rabies virus challenge in vivo and inhibits rabies virus replication in vitro. J Virol 67: 6080–6086
Lodmell DL, Smith JS, Esposito JJ, Ewalt LC (1995) Cross-protection of mice against a global spectrum of rabies virus variants. J Virol 69: 4957–4962
Lodmell DL, Sumner JW, Esposito JJ, Bellini WJ, Ewalt LC (1991) Raccoon poxvirus recobinants expressing the rabies virus nucleoprotein protect mice against lethal rabies infection. J Virol 65: 3400–3405
Morrison HG, Goldsmith CS, Regnery HL, Auperin DD (1991) Simultaneous expression of the Lassa virus N and GPC genes from a single recombinant vaccinia virus. Virus Res 18: 231–241
Sha J, Zhu JH (1995) Cloning and expression of soluble glycoprotein gene of Chinese aG rabies virus vaccine strain. Chinese J Exp Clin Virol 9: 156–160
Sonoda YT, Fujii H, Mifune K (1993) Resistance of mice vaccinated with rabies virus internal structural protein to lethal infection. Arch Virol 132: 51–65
Sumner JW, Fekadu M, Shaddock JH, Esposito JJ, Bellini WJ (1991) Protection of mice with vaccinia virus recombinants that express the rabies virus nucleoprotein. Virology 183: 703–710
Tolson ND, Charlton KM, Stewart RB, Campbell JB, Wiktor TJ (1987) Immune response in skunks to a vaccinia virus recombinant expressing the rabies virus glycoprotein. Can J Vet Res 51: 363–366
Wang JL, Zhu JH (1996) Studies on tissue culture conditions and heat stability of vaccinia virus recombinant expressing rabies virus glycoprotein. Chin J Biol Prod 9: 25–26
Wen L, Ming WY, Zhu JH, Zheng J, Li MF, Hou YD (1995) Cloning and sequencing of G protein gene of Chinese aG rabies virus vaccinia strain. Chin J Exp Clin Virol 9: 198–199
Zhao WG, Azaibi T, Zhu JH, Wang JL, Cai B, Esposito JJ (1995) Co-expression of rabies virus glycoprotein and nucleoprotein in vaccinia virus Tian Tan strain. Virol Senica 10: 15–21
Zhao WG, Ying BL, Wang JL, Cai B, Zhu YH, Hu Q, Zhu JH, Esposito JJ (1993) Rabies virus N protein expressed by recombinant vaccinia virus and the observation of its immunoeffect. Chin J Exp Clin Virol 7: 60–64
Zhu JH, Wen L, Sha J (1995) Cloning and expression of G protein gene of Chinese aG rabies virus vaccine strain. Chin J Exp Clin Virol 9: 195–197
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zhu, J.H., Wang, J., Cai, B. et al. Immunogenicity and relative attenuation of different vaccinia-rabies virus recombinants. Archives of Virology 141, 1055–1065 (1996). https://doi.org/10.1007/BF01718609
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01718609